Software to quickly assess organ dose after radionuclide exposure
Project 1: Deployable Software for the Rapid Assessment of Organ Dose Following Radionuclide Intakes
This study is creating a helpful software tool that quickly calculates how much radiation your organs absorb after you've taken certain radioactive substances, so you can get better care and treatment based on your individual needs.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11289682 on NIH RePORTER |
What this research studies
This research focuses on developing a software tool that can rapidly evaluate the dose of radiation absorbed by organs following the intake of radionuclides. By utilizing advanced algorithms and data analysis techniques, the software aims to provide timely assessments that can help in managing patient care after exposure. Patients who have been exposed to radionuclides will benefit from this tool, as it will facilitate better monitoring and treatment decisions based on their specific organ dose assessments.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who have undergone procedures involving radionuclide administration and require monitoring of their organ radiation exposure.
Not a fit: Patients who have not been exposed to radionuclides or do not require dose assessment will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance the safety and effectiveness of medical treatments involving radionuclides by providing precise organ dose evaluations.
How similar studies have performed: While the specific approach may be novel, similar software tools have shown promise in other areas of radiation assessment and management.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Bolch, Wesley E — Northwestern University at Chicago
- Study coordinator: Bolch, Wesley E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.